HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Q Xiong Selected Research
Q Xiong Research Topics
Disease
10
Neoplasms (Cancer)
03/2014 - 05/2000
7
Neoplasm Metastasis (Metastasis)
10/2001 - 05/2000
7
Adenocarcinoma
10/2001 - 11/2000
5
Pancreatic Neoplasms (Pancreatic Cancer)
07/2001 - 01/2000
3
Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 08/2016
3
Acidosis
08/2001 - 11/2000
2
Obesity
01/2018 - 11/2016
2
Hemorrhage
12/2016 - 03/2000
2
Infections
02/2014 - 10/2013
2
Melanoma (Melanoma, Malignant)
03/2001 - 05/2000
1
Insulin Resistance
11/2020
1
Diabetes Mellitus
01/2018
1
Type 2 Diabetes Mellitus (MODY)
05/2017
1
Atherosclerosis
01/2017
1
Hepatocellular Carcinoma (Hepatoma)
12/2016
1
Metabolic Diseases (Metabolic Disease)
11/2016
1
Atrial Fibrillation
08/2016
1
Heart Failure
08/2016
1
Coronary Artery Disease (Coronary Atherosclerosis)
08/2016
1
Thrombosis (Thrombus)
08/2016
1
Myocardial Infarction
08/2014
1
Ventricular Fibrillation
08/2014
1
Ventricular Tachycardia
08/2014
1
Liver Neoplasms (Liver Cancer)
03/2014
1
Cardiac Arrhythmias (Arrythmia)
03/2014
1
Esophageal Neoplasms (Esophageal Cancer)
02/2014
1
Flatulence
02/2014
1
Inflammation (Inflammations)
10/2013
1
Pain (Aches)
09/2013
1
Spinal Cord Injuries (Spinal Cord Injury)
09/2013
1
Hypoxia (Hypoxemia)
08/2001
1
Hyperthermia
08/2001
1
Hyperglycemia
08/2001
1
Pleural Effusion (Pleural Effusions)
03/2001
1
Experimental Melanoma
03/2001
1
Ascites
01/2001
1
Colonic Neoplasms (Colon Cancer)
11/2000
1
Sarcoma (Soft Tissue Sarcoma)
05/2000
1
Obstructive Jaundice (Cholestatic Jaundice)
01/2000
Drug/Important Bio-Agent (IBA)
5
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
10/2001 - 05/2000
4
Interleukin-8 (Interleukin 8)
IBA
08/2001 - 11/2000
3
Proteins (Proteins, Gene)
FDA Link
11/2020 - 11/2000
3
Nitric Oxide (Nitrogen Monoxide)
FDA Link
07/2001 - 05/2000
3
Nitric Oxide Synthase (NO Synthase)
IBA
07/2001 - 05/2000
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2001 - 03/2001
2
Messenger RNA (mRNA)
IBA
06/2001 - 11/2000
2
Lipopolysaccharides
IBA
03/2001 - 05/2000
2
NF-kappa B (NF-kB)
IBA
11/2000 - 11/2000
2
Transcription Factor AP-1 (Transcription Factor AP 1)
IBA
11/2000 - 11/2000
1
Glucose (Dextrose)
FDA Link
Generic
01/2018
1
Fibroblast Growth Factor-23
IBA
01/2017
1
Biomarkers (Surrogate Marker)
IBA
11/2016
1
P-Selectin
IBA
08/2016
1
Warfarin (Coumadin)
FDA Link
Generic
08/2016
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
08/2016
1
Fibrin
IBA
08/2016
1
Lidocaine (Xylocaine)
FDA Link
Generic
08/2014
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2014
1
Ligands
IBA
03/2014
1
Caspase 3 (Caspase-3)
IBA
03/2014
1
N(2)- (gamma- D- glutamyl)- meso- 2,2'- diaminopimelic acid
IBA
10/2013
1
Tolonium Chloride
FDA Link
09/2013
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
09/2013
1
Interferon-gamma (Interferon, gamma)
IBA
10/2001
1
Arginine (L-Arginine)
FDA Link
07/2001
1
Cytokines
IBA
07/2001
1
Luciferases
IBA
06/2001
1
Interferon-beta
IBA
01/2001
1
Transcription Factors (Transcription Factor)
IBA
11/2000
Therapy/Procedure
3
Therapeutics
08/2016 - 01/2001
1
Bariatric Surgery
05/2017
1
Operative Time
12/2016
1
Transplantation
12/2016
1
Radiofrequency Ablation
03/2014
1
Aftercare (After-Treatment)
03/2014
1
Esophagectomy
02/2014
1
Length of Stay
02/2014
1
Nutritional Support (Artificial Feeding)
02/2014
1
Conservative Treatment
03/2000
1
Drug Therapy (Chemotherapy)
01/2000